CompletedNCT05481736
COMP360 psilocybin therapy study for anorexia nervosa
About this title
Read the official source — NCT05481736Medication studyAges 18+Multiple countriesEating disorders
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- San Diego and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: October 12, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 32
- Sponsor
- COMPASS Pathways
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, United Kingdom, Ireland
- Age range
- Over 18 Years
- Official registry ID
- NCT05481736
- Official title
Show the full official title
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Diego, United States · Baltimore, United States · Austin, United States
2 more locations
- Dublin, Ireland
- London, United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is COMPASS Pathways.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin.
Who was this study for?
Listed age limits: from 18 years.
